Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

Abstract

The interim results of this phase 1 study support further investigation of base-edited T cells for patients with relapsed leukemia and indicate the anticipated risks of immunotherapy-related complications. (Funded by the Medical Research Council and others; ISRCTN number, ISRCTN15323014.).